STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

DMAC DIAMEDICA INCORPORATED StockScouter® Report

4

StockScouter® Score

DIAMEDICA INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The 50-day moving average for DMAC is significantly above its 200-day moving average. Positive
  • The multi-period measure of relative price change and consistency is above average. Positive/Neutral

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

D
N/A
N/A
B

Previous Ratings

3
3
3